Moxe Announces Funding to Accelerate Growth

Bi-directional clinical data exchange simplifies payer & provider operations

MADISON, Wis.--(BUSINESS WIRE)--Moxe, the clinical data clearinghouse simplifying healthcare operations through targeted exchange of health data, announces the company has secured an additional round of capital to fuel commercial and product expansion.

Capped by a recent investment from 3M Ventures and including previous investments by funds managed by affiliates of Apollo Global Management, Inc. (NYSE: APO), Safeguard Scientifics (NYSE: SFE), Summit Action, and UPMC Enterprises, this funding supports the rapid growth of Moxe’s network of connected payer and provider organizations

With so many resources wasted on low-value administrative efforts, Moxe addresses an area historically overlooked in the interoperability discussion, the use of clinical data to streamline a wide range of payment and operations use cases.

With an expanding network of forward-looking health plans and provider organizations who together insure more than 50 million Americans and deliver tens of millions of annual visits, Moxe is transforming the way payers and providers manage health information across the ecosystem.

Moxe’s technology connects directly to all major EMR systems to enable granular extraction of complete clinical records and sharing of actionable insights from payers to providers at the point of care. Real-time, bi-directional sharing of clinical data enables new and drastically more efficient collaboration across the healthcare ecosystem, reducing friction and realizing the promise of value based care.

With a growing industry focus on payer and provider interoperability, including a number of new regulatory requirements for standards-based APIs in 2021, Moxe is well positioned as a leader in interoperability solutions for payment and operations use cases.

“Through the uncertainty of 2020, our focus on creating real and sustained value for our clients has provided us the opportunity to continue building new ways to suck administrative waste from our system,” said Dan Wilson, founder and CEO of Moxe. “In addition to saving our clients tens of millions of dollars, we released new products to further simplify the Release of Information and streamline collaboration around the open care, risk, and quality gaps that require addressing. This investment helps us immediately scale our team for more product and market growth.”

Moxe expects to expand its team in all areas, particularly commercial, product, and engineering.

To learn more about Moxe and their mission to evolve health information management through faster, more secure clinical data exchange, visit MoxeHealth.com

About Moxe

Moxe leverages technology to improve and simplify the sharing of clinical information and critical insights between providers, payers, and patients. Moxe solutions automatically process requests for information while enforcing all appropriate release restrictions to ensure the minimum necessary release of PHI, improving areas such as risk adjustment, HEDIS and Star ratings, regulatory compliance, and more.